LAROCHE RICHARD F JR - 05 May 2022 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ Richard F. LaRoche by Kristina R. Hulsey, P.O.A.
Issuer symbol
NHC
Transactions as of
05 May 2022
Net transactions value
+$316,350
Form type
4
Filing time
06 May 2022, 15:56:05 UTC
Previous filing
12 Jan 2022
Next filing
13 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock - Held in my name or my wife's name Options Exercise $154,750 +2,500 $61.90 0 05 May 2022 Direct F1, F2
transaction NHC Common Stock - Held in my name or my wife's name Options Exercise $161,600 +2,500 +1.3% $64.64 194,313 05 May 2022 Direct F3, F4
holding NHC Common Stock - Family LP (BFLP) 30,000 05 May 2022 General Partner
holding NHC Common Stock - Fam. Partnership (LR Ent.) 31,698 05 May 2022 Direct
holding NHC Common Stock - Fam. Partnership (LFLP) 96,000 05 May 2022 General Partner

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -2,500 -100% $0.000000* 0 05 May 2022 Common Stock 2,500 $61.90 Direct
transaction NHC Option to Purchase Common Stock Options Exercise $0 -2,500 -33% $0.000000 5,000 05 May 2022 Common Stock 7,500 $64.64 Direct
transaction NHC Option to Purchase Common Stock [2022 Grant] Award $0 +7,500 $0.000000 7,500 05 May 2022 Common Stock 7,500 $69.19 Direct F5
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $72.94 Direct
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $77.92 Direct
holding NHC Option to Purchase Common Stock 7,500 05 May 2022 Common Stock 7,500 $71.64 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Transactions for this "Title of Security" totaled on the line below.
F3 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F4 Total amount of shares beneficially owned following transactions reported for this "Title of Securities" on this form.
F5 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).